Delivery Order SPE2DB24D2011-SPE2DB24FBNYD
Award Date
3/12/24
Potential Completion Date
3/13/24
Potential Value
$60K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,221.96 firm fixed-price delivery order contract is for the supply of Pulmozyme 1 mg/ml ampul 2.5 ml, a medication used to treat cystic fibrosis. The contract has an ultimate completion date of June 11, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of Pulmozyme, a pharmaceutical product used in the treatment of cystic fibrosis, to the Defense Logistics Agency (DLA). The $14,822.52 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract has a period of performance through December 13, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,849.83, is for the delivery of Pulmozyme 1 mg/ml ampul 2.5 ml, a medication used to treat cystic fibrosis. The contract has a period of performance through February 19, 2025 and is structured as a firm fixed-price delivery order. This award is part of Amerisourcebergen's...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Pulmozyme 1 mg/ml ampuls. The contract, valued at $32,686.58, is a firm-fixed-price delivery order with an ultimate completion date of January 19, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,535.06 firm fixed-price delivery order is for the supply of Pulmozyme, a 1 mg/ml ampul medication. The contract has an ultimate completion date of December 12, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division, a major pharmaceutical distributor. The $24,104.92 Firm Fixed Price Delivery Order is for the supply of Pulmozyme (dornase alfa) 1 mg/mL ampules, a medication used to treat cystic fibrosis. The contract has an ultimate completion date of July 22, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order worth $18,985.48 for the supply of Pulmozyme 1 mg/ml ampuls. The contract is with the Defense Logistics Agency Troop Support Medical and has an ultimate completion date of May 22, 2023. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00, which serves as the primary vehicle for delivering a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $4,822.00 fixed-price delivery order is for the supply of Pulmozyme 2.5ml medication, which is used to treat respiratory conditions. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 2025, that...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $61,378.77, is for the delivery of Pulmozyme 1 mg/ml ampules with a completion date of February 27, 2024. The contract is a Firm Fixed Price Delivery Order, and there is no set-aside designation, indicating it was awarded through full and open competition. AmerisourceBergen Drug Corp is a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, the prime contractor. The $59,155.92 firm fixed price delivery order is for the supply of Pulmozyme 1 mg/ml ampul 2.5 ml, a pharmaceutical product. The contract has an ultimate completion date of March 26, 2024 and does not utilize any set-aside designations. AmerisourceBergen Drug Corp, a for-profit organization, is a subsidiary of AmerisourceBergen Corporation, a leading global...